Which stocks are gapping on Thursday? The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.
Korro Bio Plummets To A Record Low On A Big Setback In RNA-Editing Korro Bio stock plummeted Thursday after its RNA-editing drug failed in patients with a rare lung and liver disease.
Stay updated with the stocks that are on the move in today's pre-market session. The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
3 Biotech Stocks Showing Strength With Big Spikes In Momentum Scores A handful of biotech stocks are showing renewed strength, with big spikes in their Benzinga Edge Ranking's Momentum scores.
Novo Nordisk Inks $600M Genetic Medicines Pact With Canadian Firm To Target Cardiometabolic Indications Wednesday, Canada-based NanoVation Therapeutics announced a multi-year partnership with Novo Nordisk A/S (
NYSE:NVO ) to advance the ...
Gene Editing Korro Bio's Preclinical Data 'Best-In-Class', Analyst Initiates With Outperform Rating William Blair initiates coverage on Korro Bio highlighting its innovative RNA editing platform, ADAR-based OPERA. The analyst rates the stock Outperform, noting its potential in treating alpha-1 antitrypsin deficiency.
KRRO Stock Earnings: Korro Bio Misses EPS for Q2 2024 KRRO stock results show that Korro Bio missed analyst estimates for earnings per share the second quarter of 2024.
KRRO Stock Earnings: Korro Bio Beats EPS for Q4 2023 KRRO stock results show that Korro Bio beat analyst estimates for earnings per share the fourth quarter of 2023.
KRRO Stock Earnings: Korro Bio Beats EPS for Q1 2024 KRRO stock results show that Korro Bio beat analyst estimates for earnings per share the first quarter of 2024.
